Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) — Nutritional High International Inc. (the “Company” or “Nutritional High“) (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to provide an update on recent developments on operations in the state of Oregon.

The Company has launched cannabis production in Oregon and successfully completed production of the first batch through the cold ethanol extraction equipment for laboratory testing. The professional laboratory testing will analyze various aspects of the product in regard to cannabinoid content, moisture, and toxins. Nutritional High implements the highest standard in cannabis testing and production in order to cultivate high quality edibles and products for the Oregon adult-use market to align with all the other existing markets.

Nutritional High is currently producing various in-house flagship FLÏ-branded products including its Vape Cartridges and Syringes. The Company is in the final stages of seeking regulatory approval in order and expects to roll out its FLÏ-branded Chocolate Bars across the state of Oregon as early as Q1 of 2019. The Chocolate Bars will come in a multitude of delicious high quality milk chocolate flavours, which include amongst others, a distinctive rich caramel, dark chocolate sea salt and dark chocolate blueberry flavour.  The Company will be working with a statewide distributor that will help market and distribute its FLÏ-branded products throughout the state.

In addition, the Company is bringing additional innovative edible products to the market with unique Chocolate Shot selling under the FLÏ-brand. The Chocolate Shot is unique to consumers in that it is engineered to stay in a delicious liquid despite external weather conditions.

“With our focus on the US West Coast, the first production in Oregon is a milestone of strategic importance to the Company,” commented Nutritional High’s Chief Executive Officer Jim Frazier. “We look forward to proudly introducing our highest quality edibles to the Oregon adult-use market and deepening our market concentration through such state-by-state development.”

Further to its press release dated November 5, 2018, the Company wishes to clarify the terms of the sale and leaseback financing agreement for equipment located at the Company’s FLÏ NorCal facility (the “Sacramento Equipment Agreement”) with Veteran Capital Corp and ASC Lease Income, LLC, (collectively, the “Sacramento Buyers”). Nutritional High issued 264,689 common share purchase warrants (each, a “Warrant”) as additional consideration in connection with the Sacramento Equipment Agreement. Each Warrant entitles the Sacramento Buyers to purchase one common share in the capital of the Company (a “Common Share”) at a price of $0.70 CDN per Common Share for a period of 24 months from the date of issuance.